Daxor
  • ABOUT DAXOR
    • Company Overview
    • Executive Team
    • Board of Directors
    • Careers
    • Contact Us
  • THE BVA-100
    • Importance Of Blood Volume Measurement
    • Blood Volume Measurement Test
    • Principle Of Blood Volume Measurement
    • Performing Blood Volume Measurement
    • Blood Volume Measurement Report
    • Resources
    • FAQ’s
  • ezBVA LAB
  • HEALTHCARE PROFESSIONALS
    • Heart Failure
    • Critical Care
    • Other Indications
    • Clinical Evidence
    • Case Studies
    • The BVA Brief Newsletter
    • Reimbursement
    • Technical Resources
    • Clinical Support Team
  • INNOVATIONS
  • INVESTORS
    • Tear Sheet
    • Press Releases
    • Executive Team
    • Board of Directors
    • Board Committees
    • Governance Documents
    • SEC Filings
    • FAQ’s
    • Key Contacts
    • Suscribe to News
  • CONTACT
  • ABOUT DAXOR
    • Company Overview
    • Executive Team
    • Board of Directors
    • Careers
    • Contact Us
  • THE BVA-100
    • Importance Of Blood Volume Measurement
    • Blood Volume Measurement Test
    • Principle Of Blood Volume Measurement
    • Performing Blood Volume Measurement
    • Blood Volume Measurement Report
    • Resources
    • FAQ’s
  • ezBVA LAB
  • HEALTHCARE PROFESSIONALS
    • Heart Failure
    • Critical Care
    • Other Indications
    • Clinical Evidence
    • Case Studies
    • The BVA Brief Newsletter
    • Reimbursement
    • Technical Resources
    • Clinical Support Team
  • INNOVATIONS
  • INVESTORS
    • Tear Sheet
    • Press Releases
    • Executive Team
    • Board of Directors
    • Board Committees
    • Governance Documents
    • SEC Filings
    • FAQ’s
    • Key Contacts
    • Suscribe to News
  • CONTACT
News
11 Sep 2023

Daxor Corporation Awarded $305K Grant from the National Institutes of Health to Develop Blood Volume Guidance Software in Sepsis Patients

admin
News
07 Sep 2023

Daxor Corporation to Present at the H.C. Wainwright 25th Annual Global Investment Conference

admin
News
28 Aug 2023

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders

admin
News
28 Aug 2023

Daxor Corporation Reports a 20.64 Percent Increase in Diagnostic Test Kits Revenue From Prior Year Period in Form N-CSR Filing for the Six Months Ended June 30, 2023

admin
News
10 Aug 2023

JACC-HF Reports Successful Heart Failure Trial With Daxor BVA-100®

admin
News
12 Jul 2023

JACC-HF Study Compares Daxor’s BVA-100® Volume Metric to CardioMEMS® Pressure Metric in Heart Failure Patients

admin
News
11 Jul 2023

Daxor Corporation Announces Further Acquisitions and Increased Utilization of its BVA-100® Blood Volume Diagnostic Throughout the U.S.

admin
News
05 Jul 2023

Daxor Corporation Awarded $1.1 Million Contract from the United States Defense Health Agency for Added Capabilities to its Point-of-Care Blood Volume Analyzer

admin
News
22 Jun 2023

Daxor Corporation Announces Partial Exercise of Over-Allotment Option in Secondary Offering

admin
News
20 Jun 2023

Daxor Corporation to Showcase the Benefits of BVA-100® Guided Care at the American Association of Heart Failure Nurses (AAHFN) 19th Annual Meeting

admin
Previous